When non-small cell lung cancer (NSCLC) spreads beyond the lungs, it often metastasizes to the bones. Estimates suggest 20 to 30 percent of people with NSCLC have bone metastases at the time of ...

This work presents a Computer Aided Diagnosis (CAD) system that helps radiologists in differentiating malignant and benign bone lesions in the spine on Computed Tomography (CT) images usingSupport ...

Multiple myeloma causes lytic or osteolytic lesions, which are areas of damage caused by cancerous plasma cells blocking normal bone growth. While painful, they can be managed. Multiple myeloma is ...

Lesion (MS lesion). Multiple Sclerosis Trust. January 5, 2024. Ruggieri S et al. The added value of spinal cord lesions to disability accrual in multiple sclerosis. Journal of Neurology. June 29 ...

In multiple sclerosis (MS), diffuse degenerative processes in the deep grey matter have been associated with clinical disabilities. We performed a systematic study in MS deep grey matter with a focus ...

Tuesday, June 10, 2025. News & Perspective Drugs & Diseases CME & Education Video Decision Point close ...

PHOENIX — Frexalimab, a second-generation anti-CD40 ligand monoclonal antibody provides extended tight control of multiple sclerosis (MS) whether measured by relapse or brain imaging at 2-year ...

Ocrevus (ocrelizumab) appears to be safe and effective for children and adolescents with multiple sclerosis (MS), according to real-world data from Kuwait. After about 15 months of treatment, more ...

Automating Multiple Sclerosis (MS) lesion segmentation would be of great benefit in initial diagnosis as well as monitoring disease progression. Deep learning based segmentation models perform well in ...